Will Merck and Ridgeback Biotherapeutics' antiviral drug against Covid-19 be considered safe and effective by the end of 2021?
FutuurClosedVerified resolution dataThis market resolved: Yes (28%)
Resolved: Dec 23, 2021, 6:29 PM
Provider-verified resolution
CoinRithm has provider-backed winner and settlement-time evidence for this market.
Data quality warningStale dataNot meaningfully priced
Data as of Dec 23, 2021, 6:29 PM UTC · policy pm-quality-3
Current implied probabilityNo 72%
Market quality
15 / 100
Low quality24h Volume
—
Liquidity
—
Liquidity unknownTraders
2
Market data
Updated 1,706 days ago
StaleTrends
72%
28%
Rules
Resolution criteria are not yet available for this market. Refresh cycles will populate this section when source rules are stored.
Frequently asked questions
- What are the current odds for Will Merck and Ridgeback Biotherapeutics' antiviral drug against Covid-19 be considered safe and effective by the end of 2021??
- Futuur prices No at 72% as of December 23, 2021.
- When does Will Merck and Ridgeback Biotherapeutics' antiviral drug against Covid-19 be considered safe and effective by the end of 2021? resolve?
- Will Merck and Ridgeback Biotherapeutics' antiviral drug against Covid-19 be considered safe and effective by the end of 2021? is scheduled to resolve on December 31, 2021.